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Abstract
Background: External and intraocular infections can lead to visual impairments, which is a major public health
problem. Bacteria are the most frequent pathogens affecting ocular structures; the increasing rate of antimicrobial
drug resistance is a worldwide concern. The aim of this study was to determine the occurrence of bacteria in ocular
infections, their antimicrobial susceptibility patterns, and risk factors in bacterial ocular infection.
Methods: A hospital based cross-sectional study was conducted from September 2015 to December 2015 at
Quiha Ophthalmic Hospital, Tigray, northern Ethiopia. Ocular specimens from blepharitis, blepharoconjunctivitis,
conjunctivitis, keratitis, endophthalmitis, periorbital cellulitis and dacrocystitis were collected from 270 individuals
with suspected ocular infection. Data on sociodemographic and risk factors were also collected using a structured
questionnaire. Data analysis was performed using SPSS version 21 and 0.05 with a corresponding 95% confidence
interval (CI) was considered statistically significant.
Results: Among 270 study subjects, 180 (66.7%) were culture positive for different bacterial isolates. The
predominant bacterial isolates were Staphylococcus aureus (40, 22.2%), coagulase negative staphylococci (31, 17.2%)
and Pseudomonas aeruginosa (21, 11.7%). Ocular surface disease, ocular trauma, hospitalization and cosmetic
application practices were significantly associated with the occurrence of bacterial infection. Concerning
antimicrobial susceptibility, most isolates were susceptible to amikacin (137, 93.2%), gentamicin (131, 89.1%) and
ciprofloxacin (141, 89.2%). Overall, 40 (22.5%), 34 (19.1%) and 62 (34.8%) isolates were resistant to one, two, and
three or more antimicrobials, respectively.
Conclusion: Bacteria were isolated from the majority of the study subjects. More than half of the bacterial isolates
were resistant at least to one drug and a significant rate of multidrug resistance was detected. Therefore,
identification of the etiologic agent and antimicrobial susceptibility testing should be practiced to select the
appropriate antimicrobial agent to treat eye infections and prevent the emergence of drug resistant bacteria.
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Background
The eye, a functionally and structurally complex organ, ex-
periences a variety of bacterial, viral, fungal and parasitic in-
fections [1–3]. Bacterial infections (Both Gram-positive and
Gram-negative) contribute to 32 to 74% of ocular infections
globally [4–10]. Staphylococci are the leading ocular isolates
worldwide among the Gram-positive bacteria, [9, 11–13];
while Pseudomonas aeruginosa, Klebsiella pneumoniae and
Escherichia coli are the major Gram-negative bacteria iso-
lated from ocular infections [3, 14, 15].
Bacteria are the most common agents causing external
ocular infections, including blepharitis, keratitis, dacryocysti-
tis, and orbital cellulitis. Bacteria are responsible for 70–80%
of conjunctival morbidity which poses a huge socioeco-
nomic burdens to the general public [16–19]. Blepharitis, an
inflammation of the eyelid, can cause complete loss of the
eyelashes if not diagnosed early [20]. Bacterial keratitis is the
leading cause of corneal blindness [18, 21, 22].
External ocular infections may remain localized, or pro-
gress to adjacent tissues. For instance, external and in-
ternal hordeolum can result from the spread of eyelid
infection to the respective glands [23]. Dacryocystitis, in-
flammation of the nasolacrimal duct, is the result of naso-
lacrimal duct obstruction. The accumulation of fluid and
edema in the eye secondary to dacryocystitis, is a potential
danger to ocular tissues such as the cornea and conjunc-
tiva [24, 25]. External ocular infections that result from
systemic spread, surgery or are secondary to ocular
trauma, can lead to sight threatening intraocular infections
such as endophthalmitis [1, 22, 26, 27]. Left untreated,
bacterial ocular infections, bacterial products and vigorous
inflammation following infection, can irreversibly damage
ocular structures [28, 29]. Inflammation and scarring,
once present, may not be easily resolved and can result in
visual impairment or permanent loss of vision [30, 31].
Additionally, bacterial ocular infections have been com-
plicated by multidrug resistance;, a problem that is inten-
sifying over time [32, 33]. This poses a challenge in the
clinical management of bacterial ocular infections [34–36].
Eye infections are remarkably common in northern
Ethiopia; however, no studies have been conducted on this
topic in this region. Similarly, the antimicrobial suscepti-
bility patterns of infecting bacteria in this region are not
known. Therefore, we sought to determine the ocular
bacterial infection, the risk factors and the antimicrobial
susceptibility of bacterial isolates in ocular infections at
Quiha Ophthalmic Hospital, Tigray, northern Ethiopia.
Methods
Study design, data and specimens collection
A hospital based cross-sectional study was conducted
from September-December 2015 in Quiha Ophthalmic
Hospital, Quiha, Tigray, Ethiopia. A total of 270 patients
who presented with suspected ocular infection were
consecutively included in the study. Sociodemographic,
clinical and risk-factor related data were collected using a
pretested structured questionnaire using interviewer-
administered questionnaires. Study subjects were examined
using a slit-lamp biomicroscope to screen for the presence
of ocular infection. Ocular specimens were collected from
periorbital cellulitis (N = 8), dacryocystitis (N = 13), blephar-
itis (N = 26), blepharoconjunctivitis (N = 16), conjunctivitis
(N = 123), keratitis (N = 57) and endophthalmitis (N = 27)
diagnoses. An ophthalmic surgeon collected specimens
from all patients except those patients who had endoph-
thalmitis who had their specimemens collected by an
ophthalmologist [37–39].
Specimen transportation
The respective specimens were then transferred into 2 ml
of brain-heart infusion broth (Oxoid, Hampshire, UK).
Tubes were tightly capped, gently mixed, labeled and
placed in cold chain. Finally, samples were transported to
the Microbiology Laboratory, Mekelle University, for
microbiological analysis [38, 39].
Cultivation and identification of isolates
The broth was gently mixed to homogeneity; 100 μl of
inoculum was then dispensed and streaked onto blood
agar, chocolate agar, MacConkey agar, Mannitol salt agar
and modified Thayer-Martin agar (MTM) (Oxoid,
Hampshire, UK). To maintain the presence of CO2,
chocolate agar and MTM agar plates were placed in
candle jars. All media were incubated overnight at 37 °C.
After 24 h of incubation, each plate was inspected for
any growth and negative plates were incubated for an
additional 24 h. For eyelid and conjunctival swabs,
culture positivity was determined based on a threshold
criteria. Corneal specimens were considered as positive
if there was a confluent growth at the site of inoculation
[39]. All bacterial isolates were identified using standard
clinical laboratory methods [40, 41].
Antimicrobial susceptibility testing
Antimicrobial susceptibility testing was performed using
the standard Kirby-Bauer disk diffusion method [41].
For fastidious organisms, Muller-Hinton agar with 5%
sheep blood was used and incubated in 5% CO2; GC
agar and Haemophilus Test Medium were used for
Neisseria gonorrhoeae and Haemophilus influenzae, re-
spectively [42]. The following antibiotics were used:
trimethoprim-sulfamethoxazole (SXT; 1.25/23.75 μg),
erythromycin (15 μg), clarithromycin (15 μg), chloram-
phenicol (30 μg), clindamycin (2 μg), tetracycline
(30 μg), doxycycline (30 μg), amikacin (30 μg), gentami-
cin (10 μg), ciprofloxacin (5 μg), ceftriaxone (30 μg) and
cefoxitin (30 μg) (HIMEDIA). The zones of inhibition of
the antimicrobial agents were measured using calipers;
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bacteria were described as susceptible or resistant based
on CLSI guideline [42]. Multidrug resistance was defined
as non-susceptible to ≥1 agent in ≥3 antimicrobial
categories according to the definition of Magiorakos and
colleagues [43].
Quality assurance
Standard operational procedures were strictly followed
from the pre-analytical to the post-analytical phase. The
questionnaire was pretested on 16 patients with ocular
infection. Data collectors were trained on data collection
procedures. Completed questionnaires were proofread
immediately after completion by the research team to
clarify any labelling errors or illegibility. Standard
Operating procedures were followed during Specimen
collection, handling, transportation, microbiological ana-
lysis and interpretation of results. Reagents, media and
antimicrobial disks were checked for the expiry date,
damage and storage problems. Media sterility was
strictly monitored by random sampling and incubation
to test for any growth. In addition, reference strains of
Staphylococcus aureus ATCC25923, E. coli ATCC25922
and P. aeruginosa ATCC27853 were used to monitor the
quality of this work [42].
Statistical analysis
Data was entered into SPSS version 21, and descriptive
statistics, bivariate and multivariate logistic regression
analyses were performed. Bivariate logistic regression
was employed to look for association between the out-
come variable and independent variables. Variables
with P-values <0.05 were reanalyzed in multivariate
logistic regression to identify risk factors for bacterial
occurrence. The corresponding P-value <0.05 and the




A total of 270 study subjects with clinically diag-
nosed ocular infections were included in the study,
of whom 151 (55.9%) females, 119 (44.1%) were
males and 158 (58.5%) were rural dwellers (Table 1).
The mean (SD) age of the study subjects was 37.8
(22.9) years.
Bacterial profile and clinical features
Conjunctivitis (123 cases of 270, 45.6%) was the leading
clinical presentation, followed by keratitis (57, 21.1%),
endophthalmitis (27, 10.0%), blepharitis (26, 9.6%), ble-
pharoconjunctivitis (16, 5.9%), dacryocystitis (13, 4.8%),
and periorbital cellulitis (8, 3.0%) (Table 2). Of the total
270 patients, 180 (66.7%) were culture positive for
bacterial isolates. Single and mixed bacterial infection
Table 1 Sociodemographic characteristics of the study subjects
(N = 270)
























1–8 grades 66 24.1
9–12 grades 34 12.6
College and above 18 6.7
No formal education 122 45.2
Total 270 100
Table 2 The distribution of culture positive samples in ocular
infection
Clinical diagnosis Bacterial Culture positive Total, N (%)
No (%) Yes (%)
Periorbital cellulitis 1 (12.5) 7 (87.5) 8 (100)
Dacryocystitis 1 (7.7) 12 (92.3) 13 (100)
Blepharitis 12 (46.2) 14 (53.8) 26 (100)
Blepharoconjunctivitis 10 (62.5) 6 (37.5) 16 (100)
Conjunctivitis 48 (39) 75 (61) 123 (100)
Keratitis 11 (19.3) 46 (80.7) 57 (100)
Endophthalmitis 7 (25.9) 20 (74.1) 27 (100)
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patients were seen in 174 (96.7%) and 6 (3.3%) cases, re-
spectively (Table 2). The mixed isolates were detected
from three patients with conjunctivitis, one patient with
periorbital cellulitis, one with keratitis and one with en-
dophthalmitis diagnosis.
Bacterial infection was significantly higher in patients
with dacryocystitis 92.3% (COR = 20, 95% CI: 2.0–195,
P = 0.01), periorbital cellulitis 87.5% (COR = 11.7, 95%
CI: 1.1–183.8, P = 0.03), keratitis 80.7% (COR = 6.9, 95%
CI: 2.0–23.3, P < 0.01) and endophthalmitis 74.1% (COR =
4.7, 95% CI: 1.2–17.9, P = 0.02) than for the other diagno-
ses (Table 2).
Identification of bacterial isolates
In this study, 113 (60.7%) bacterial isolates were Gram-
positive, and 87 (39.3%) were Gram-negative. Overall,
the dominant bacterial isolates were S. aureus (40,
21.5%) followed by coagulase-negative staphylococci
(CoNS; 31, 16.7%), P. aeruginosa (21, 11.3%) and E. coli
(15 8%) (Table 3).
Risk factors for bacterial occurrence in ocular infections
In this study, 11 independent variables were considered
during the bivariate analysis of risk factors for bacterial
infection. In multivariate analysis, ocular surface disease
(AOR = 13.6, 95% CI: 3.8 49.3, P < 0.01), ocular trauma
(AOR = 4.2, 95% CI: 1.4–13, P = 0.012), hospitalization
(AOR = 3.3, 95% CI: 1.03–12.5, P = 0.04), and cosmetic
application practices (AOR = 4.7, 95% CI: 1.6–13.9 P <
0.01) were significantly associated with bacterial occur-
rence (Table 4). Though not statistically significant,
bacterial occurrence was higher in housewives 32 (74.4%)
(COR = 2.3, 95% CI: 0.6–9.0, P = 0.06) and in those
subjects with no formal education 90 (73.8%) (COR = 1.8,
95% CI: 0.6–5.0, P = 0.2) (Table 5).
Antimicrobial susceptibility pattern of bacterial isolates
In this study, the majority of bacterial isolate were
susceptible to ciprofloxacin (141, 89.2%), amikacin (137,
93.2%), gentamicin (131, 89.1%), chloramphenicol (106,
70.2%), and doxycycline (100, 71.9%). However, bacterial
isolates were less susceptible to tetracycline (79, 51.3%)
Table 3 The distribution of bacteria according to clinical diagnosis
Type of bacterial
isolate, N (%)
Clinical diagnosis Total N (%)
P’orbital cellulitisa Dacryocystitis Blepharitis Blepharoconjunctivitis Conjunctivitisb Keratitisc Endophthalmitisd
S. aureus 4 (50) 3 (25) 5 (38.5) 2 (33.3) 17 (21.5) 7 (14.9) 2 (9.5) 40 (21.5)
CoNSe 0 0 3 (23.1) 1 (16.7) 13 (16.5) 8 (17) 6 (28.6) 31 (16.7)
S. pyogenes 1 (12.5) 3 (25) 0 0 1 (1.3) 0 0 5 (2.7)
S. pneumoniae 2 (25) 2 (16.7) 0 1 (16.7) 3 (3.8) 0 0 8 (4.3)
Viridans streptococci 0 0 0 0 6 (7.6) 1 (2.1) 0 7 (3.8)
Enterococcus spp. 0 0 0 0 6 (7.6) 2 (4.3) 0 8 (4.3)
Moraxella spp. 1 (12.5) 0 0 0 0 1 (2.1) 0 2 (1.1)
N. gonorrhoeae 0 0 0 0 1 (1.3) 0 0 1 (0.5)
H. influenzae 0 0 0 0 2 (2.5) 0 0 2 (1.1)
P. aeruginosa 0 0 1 (7.7) 0 2 (2.5) 11 (23.4) 7 (33.3) 21 (11.3)
K. pneumoniae 0 1 (8.3) 1 (7.7) 0 2 (2.5) 1 (2.1) 2 (9.5) 7 (3.8)
Klebsiella spp. 0 1 (8.3) 0 0 2 (2.5) 2 (4.3) 0 5 (2.7)
E. coli 0 1 (8.3) 1 (7.7) 1 (16.7) 7 (8.9) 4 (8.5) 1 (4.8) 15 (8.1)
Enterobacter spp. 0 1 (8.3) 1 (7.7) 0 5 (6.3) 3 (6.4) 0 10 (5.4)
Citrobacter freundii 0 0 0 0 2 (2.5) 2 (4.3) 0 4 (2.2)
S. marcescens 0 0 0 1 (16.7) 3 (3.8) 1 (2.1) 0 5 (2.7)
Aeromonas spp. 0 0 0 0 1 (1.3) 1 (2.1) 0 2 (1.1)
P. shigelloides 0 0 0 0 1 (1.3) 0 0 1 (0.5)
Proteus spp. 0 0 0 0 2 (2.5) 1 (2.1) 0 3 (1.6)
Acinetobacter spp. 0 0 1 (7.7) 0 1 (1.3) 2 (4.3) 1 (4.8) 5 (2.7)
GPBf 0 0 0 0 2 (2.5) 0 2 (9.5) 4 (2.2)
Total 8 (100) 12 (100) 13 (100) 6 (100) 79 (100) 47 (100) 21 (100) 186 (100)
Notes: amixed isolate in one case: S. pneumoniae + H. influenzae; bmixed isolates in three cases: E. coli + P. aeruginosa; E. coli + S. aureus & S. marcescens + S. aureus ;
cmixed isolate in one case: P. aeruginosa + S. aureus ; dmixed isolate in one case: E. coli + CoNS; eCoNS Coagulase negative staphylococci; fGPB Gram-positive bacilli,
P’orbital cellulitis = Periorbital cellulitis
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and SXT (66, 48.7%). Among the Gram-negative
bacteria, 47 bacterial isolates (83%) were susceptible to
ceftriaxone. In addition, 79 (70.7%) of the Gram-positive
isolates were susceptible to erythromycin. All isolates
of S. pyogenes, S. pneumoniae, viridans streptococci
and H. influenzae were susceptible to clarithromycin.
Methicillin-resistance was observed in 7 (17.5%) S.
aureus and 14 (45.2%) CoNS isolates (Table 6).
Overall, 40 (22.5%) bacterial isolates were resistant to
at one antimicrobial agent; 96 (53.9%) were resistant to
≥2 antimicrobials (Table 7). A standard definition of
MDR was applied for isolates of S. aureus, members of
the Enterobacteriaceae and Acinetobacter spp. [43], by
which 18 (45%) S. aureus, 17 (31.5%) isolates of Entero-
bacteriaceae, and one Acinetobacter isolate were found
to be MDR. Among Enterobacteriaceae, Klebsiella spp.
(6, 50%) and E. coli (7, 46.7%) were the commonest
MDR isolates (Table 8).
Discussion
Our assessment revealed that a high proportion of ocu-
lar infections (66.7%) were due to bacterial infections
elsewhere in Ethiopia, lower proportions have been ob-
served (48.8–60.8%) [10, 11, 44]; however, higher pro-
portions (74.7%) have been observed in Jimma, Ethiopia
[6]. This variation could be attributed to the inclusion
of only exra-ocular infection in other studies. Our
observations were also higher than that seen in India
(34.5%) [3], Japan (32.2%) [4], and Iran (37.5%) [45];
sociodemographic, geographical or climatic differences
for the patient populations could partially explain this
[38]. Similar to findings from India [46], Iran [9], and
other studies in Ethiopia [6, 10, 11, 44], Gram-positive
bacteria contributed to majority (60.7%) of the total
bacterial isolates in our study. Overall, the predominant
bacterial isolate was S. aureus (21.5%), as has been re-
ported in Jimma (28.4%) [6], Gondar (21%) [10], Nigeria
(23.7%) [23], and India (26.6%) [47]. Staphylococcal
isolates were predominant among patients with con-
junctivitis, blepharitis and blepharoconjunctivitis diag-
noses, similar to that in patients from Jimma [6],
Nigeria [23], and Columbia [48]. Conversely,, CoNS
isolates were more frequent in keratitis (17%) and en-
dophthalmitis (28.6%) diagnoses, as has been reported
in Uganda [49], Mexico [50], Australia [8], Pakistan
[51] and India [52].
As compared to published literature from other areas
in Ethiopia, Nigeria, UK, Australia and India, most
streptococcal isolates were from conjunctivitis diagnoses,
with some isolates from blepharoconjunctivitis and kera-
titis. In the literature, Staphylococci and streptococci are
known to be the main agents of post-traumatic
periorbital cellulitis [54]; in our study, S. aureus (50%), S.
pneumoniae (12.5%) and S. pyogenes (12.5%) were the
main Gram-positive isolates from periorbital cellulitis.
As has been seen in Gondar [19], Borumeda [44], and
India [47], S. pneumoniae and S. pyogenes were the
predominant species among patients with dacryocystitis.
The most common isolates among the Gram-negative
bacteria were P. aeruginosa (11.3%), E. coli (8.1%) and
Klebsiella spp. (6.4%) as has been seen in Hawassa;
however, the proportions of P. aeruginosa (4.9%) and E.
coli (4.9%) observed in Hawassa were lower than in our
study [23]. This may be due to the additional isolates from
endophthalmitis diagnoses we identified.
P. aeruginosa was the predominant isolate in keratitis
(23.4% of diagnoses) similar to findings reported in
Nigeria (23.8%) [23], the UK (24.3%) [7], Australia (21%)
Table 4 Multivariate logistic regression analysis of factors associated with ocular bacterial infections
Variable Bacterial occurrence, N (%) Total, N (%) CORa (95% CIb), P-value AORc (95% CI), P-value
No Yes
History of ocular surface disease
Yes 10 (11.0) 81 (89.0) 91 (100) 6.5 (3.2–13.4), <0.01 13.6 (3.8–49), <0.01
No 80 (44.7) 99 (53.3) 179 (100) 1 1
History of ocular trauma
Yes 14 (16.7) 70 (83.3) 84 (100) 3.4 (1.8–6.5), <0.01 4.2 (1.4–13), 0.012
No 76 (40.9) 110 (59.1) 186 (100) 1 1
History of hospitalization
Yes 9 (13.4) 58 (86.6) 67 (100) 4.3 (2–9), <0.01 3.3 (1.03–12.5), 0.04
No 81 (39.9) 122 (60.1) 203 (100) 1 1
Cosmetic application practices
Yes 7 (12.1) 51 (87.9) 58 (100) 5.3 (2.2–12.8), <0.01 4.7 (1.6–13.9), <0.01
No 39 (41.9) 54 (58.1) 93 (100) 1 1
Notes: aCOR Crude odds ratio; bCI Confidence interval; cAOR Adjusted odds ratio
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Table 5 Bivariate logistic regression analysis of factors associated with ocular bacterial infections
Variable Bacterial occurrence N (%) Total
N (%)
CORa 95% CIb P-value
No Yes
Gender
Male 41 (34.5) 78 (65.5) 119 (100) 0.9 0.5–1.5 0.7
Female 49 (32.5) 102 (67.5) 151 (100) 1
Age
15 28 (48.3) 30 (51.7) 58 (100) 1
16–30 15 (30.6) 34 (69.4) 49 (100) 2.1 0.9–4.6 0.06
31–45 17 (26.6) 47 (73.4) 64 (100) 2.6 1.2–5.5 0.01
46–60 14 (27.5) 37 (72.5) 51 (100) 2.5 1.1–5.5 0.02
61 16 (33.3) 32 (66.7) 48 (100) 1.8 0.8–4.1 0.1
Residence
Rural 48 (30.4) 110 (69.6) 158 (100) 0.7 0.4–1.2 0.22
Urban 42 (37.5) 70 (39.1) 112 (100) 1
Occupation
Preschool 13 (43.3) 17 (56.7) 30 (100) 1.0 0.4–2.7 0.8
Student 18 (45.0) 22 (55.0) 40 (100) 1
Housewife 11 (25.6) 32 (74.4) 43 (100) 2.3 0.9–6.0 0.06
Farmer 25 (27.5) 66 (72.5) 91 (100) 2.1 0.9–4.6 0.051
Government employee 13 (38.2) 21 (61.8) 34 (100) 1.3 0.5–3.3 0.2
Self-employed 10 (31.3) 22 (68.8) 32 (100) 1.8 0.6–4.7 0.2
Educational level
Preschool 13 (43.3) 17 (56.7) 30 (100) 0.8 0.25–2.7 0.7
1–8 28 (42.4) 38 (57.6) 66 (100) 0.9 0.3–2.5 0.8
9–12 10 (29.4) 24 (70.6) 34 (100) 1.5 0.7–4.2 0.2
College and above 7 (38.9) 11 (61.1) 18 (100) 1
No formal education 32 (26.2) 90 (73.8) 122 (100) 1.8 0.6–5.0 0.2
History of ocular surface disease
Yes 10 (11.0) 81 (89.0) 91 (100) 6.5 3.2–13.4 <0.01
No 80 (44.7) 99 (53.3) 179 (100) 1
History of Ocular surgery
Yes 14 (24.6) 43 (75.4) 57 (100) 1.7 0.8–3.3 0.11
No 76 (35.7) 137 (64.3) 213 (100) 1
History of Ocular trauma
Yes 14 (16.7) 70 (83.3) 84 (100) 3.4 1.8–6.5 <0.01
No 76 (40.9) 110 (59.1) 186 (100) 1
History of Hospitalization
Yes 9 (13.4) 58 (86.6) 67 (100) 4.3 2–9 <0.01
No 81 (39.9) 122 (60.1) 203 (100) 1
Contact lens use
Yes 4 (30.8) 9 (69.2) 13 (100) 1.1 0.3–3.7 0.8
No 86 (33.5) 171 (66.5) 257 (100) 1
Cosmetic application practices
Yes 7 (12.1) 51 (87.9) 58 (100) 5.3 2.2–12.8 <0.01
No 39 (41.9) 54 (58.1) 93 (100) 1
Notes: aCOR Crude odds ratio; bCI Confidence interval; P-values in bold are statistically significant
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[8], and Iran (24.7%) [15]. Pseudomonal keratitis is a
progressive infection with large infiltrate and scarring
[22, 53]; this therefore means majority of patients in our
population are at risk of blindness.
Our assessment illustrated that the presence of ocular
surface disease, ocular trauma, hospitalization and cos-
metic application practices were significantly associated
with the occurrence of bacterial infection. Risk factors
for bacterial ocular infections that have been described
include a history of hospital stay in Columbia and
Portugal [48, 55], ocular trauma in Australia, Florida,
Iran, China and Mexicao [1, 8, 15, 22, 50] and ocular
disease in Florida and Colombia [22, 48] Cosmetic appli-
cation practices were considered only for female partici-
pants. Limited information exists on the relationship
between cosmetic application practices and bacterial
ocular infections.
Almost one quarter of the bacterial isolates in were sus-
ceptible to all of the tested antimicrobials. Resistance to
two or more antimicrobials was seen in 53.9% of the iso-
lates, which is lower than that reported in other regions in
Ethiopia (69.9–87.1%) [10, 11]. S. pneumoniae (87.5%),
CoNS (87%) and S. aureus (82.5%) were the most resistant
among Gram-positive isolates. Acinetobacter spp. (100%),
Table 7 Level of antimicrobial resistance in bacteria isolated from ocular infections
Type of bacterial isolate Level of resistance N (%) Total
R0 R1 R2 R3 R4
Gram-positive S. aureus 7 (17.5) 8 (20) 6 (15) 7 (17.5) 12 (30) 40 (100)
CoNSa 4 (12.9) 6 (19.4) 5 (16.1) 0 16 (51.6) 31 (100)
S. pyogenes 3 (60) 2 (40) 0 0 0 5 (100)
S. pneumoniae 1 (12.5) 2 (25) 4 (50) 0 1 (12.5) 8 (100)
Viridans streptococci 2 (28.6) 2 (28.6) 2 (28.6) 1 (14.3) 0 7 (100)
Enterococcus spp. 2 (25) 1 (12.5) 4 (50) 1 (12.5) 0 8 (100)
Total 19 (19.2) 21 (21.2) 21 (21.2) 9 (9) 29 (29.3) 99 (100)
Gram-negative N. gonorrhoeae 1 (100) 0 0 0 0 1 (100)
H. influenzae 1 (50) 1 (50) 0 0 0 2 (100)
P. aeruginosa 10 (47.6) 9 (42.9) 2 (9.5) 0 0 21 (100)
K. pneumoniae 0 0 1 (14.3) 5 (71.4) 1 (14.3) 7 (100)
Other Klebsiella spp. 0 2 (40) 1 (20) 1 (20) 1 (20) 5 (100)
E. coli 5 (33.3) 2 (13.3) 1 (6.7) 1 (6.7) 6 (40) 15 (100)
Enterobacter spp. 2 (20) 2 (20) 3 (30) 1 (10) 2 (20) 10 (100)
Citrobacter freundii 1 (25) 0 1 (25) 1 (25) 1 (25) 4 (100)
S. marcescens 2 (40) 1 (20) 0 1 (20) 1 (20) 5 (100)
P. shigelloides 1 (100) 0 0 0 0 1 (100)
Proteus spp. 0 0 2 (66.7) 1 (33.3) 0 3 (100)
Acinetobacter spp. 0 2 (40) 1 (20) 1 (20) 1 (20) 5 (100)
Total 23 (29.1) 19 (24) 13 (16.5) 11 (13.9) 13 (16.5) 79 (100)
Grand Total 42 (23.6) 40 (22.5) 34 (19.1) 20 (11) 42 (23.5) 178 (100)
Notes: R0 Susceptible to all tested antimicrobials, R1 Resistant to one antimicrobial, R2 Resistant to two antimicrobials, R3 Resistant to three antimicrobials, R4
Resistant to four or more antimicrobials; aCoNS Coagulase negative staphylococci
Table 8 Multidrug resistance patterns of bacterial isolates from
ocular infections
Type of bacterial isolate Total number of isolates MDRa isolates, N (%)
S. aureus 40 18 (45)
K. pneumoniae 7 4 (57.1)
Other Klebsiella spp. 5 2 (40)
E. coli 15 7 (46.7)
Enterobacter spp. 10 2 (20)
Citrobacter freundii 4 1 (25)
Serratia marcescens 5 1 (20)
P. shigelloides 1 0
Proteus spp. 3 0
Acinetobacter spp. 5 1 (20)
Total 95 36 (37.9)
Notes: aMDR Multi-drug resistant: non-susceptible to 1 agent in 3 antimicrobial
categories [43]. Based on this definition, the following antimicrobial categories
were considered to determine whether the given isolate is MDR: S. aureus:
aminoglycosides, methicillin, SXT, clindamycin, chloramphenicol, macrolides
(erythromycin), tetracyclines and fluoroquinolones (ciprofloxacin). Enterobacteriaceae:
aminoglycosides, ceftriaxone, fluoroquinolones (ciprofloxacin), SXT, chloramphenicol
and tetracyclines. Acinetobacter spp.: aminoglycosides, fluoroquinolones
(ciprofloxacin), ceftriaxone, SXT and tetracyclines
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Klebsiella spp. (100%) and Enterobacter spp. (80.0%) were
the most resistant among Gram-negative isolates. which is
lower than that reported in other studies [56, 57].
Here, relatively, amikacin (93.2%), gentamicin (89.1%)
and ciprofloxacin (89.2%) were revealed high efficacy
towards Gram-positive and Gram-negative isolates.
Studies in Gondar have reported lower susceptibility to
gentamicin (54.8%) and ciprofloxacin (74.2%) [10, 19];
differences in the variety of isolates tested may partly
explain this. Outside Ethiopia, comparable susceptibility
patterns to amikacin, ciprofloxacin and chloramphenicol
were reported in Iran [15] and India [47]. However, the
gentamicin susceptibility in this study is much higher than
that in the study conducted in India (58.6%) [47]; regional
variations in antibiotic prescription practices could explain
this [38]. The resistance we observed to tetracycline and
erythromycin was high, and this paralleled a study from
India [3]. High resistance is usually due to the over use
and empirical treatment of patients that ultimately leads
to the emergence of drug resistant strains [58, 59].
Methicillin resistance was seen in 17.5% of the isolated
S. aureus, which is in line with a study conducted in
India (14%) [60], but lower than the rates in Taiwan
(52.8%) [57] and Uganda (31.9%) [49]. In addition, 45.2%
of CoNS were methicillin resistant, which was higher
than detected in Uganda (27.6%) [49]. To date, other
than a study conducted in Gondar, most studies in
Ethiopia did not determine methicillin resistance rates
for ocular staphylococcal isolates [19]. Our study was
not without limitation; we did not isolate anaerobic
bacteria or Chlamydia trachomatis due to unavailability
of the prerequisite facilities. We also did not determine
the antimicrobial susceptibility of Moraxella species or
Aeromonas species due to a lack of antimicrobials for
agar dilution.
Conclusions
In conclusion, a high prevalence of bacteria was found
in patients with ocular infection. “Ocular surface disease,
ocular trauma, hospitalisation and cosmetic application
practices were significantly associated with the occur-
rence of bacterial infection. Overall, S. aureus, CoNS,
and P. aeruginosa were the predominant isolates. The
majority of the bacterial isolates were multidrug resist-
ant. Methicillin resistance was higher in CoNS than in
S. aureus. S. pneumoniae, CoNS of which S. aureus was
the most resistant species among Gram-positive iso-
lates; Klebsiella species and E. coli were most resistant
among Gram-negative isolates. Identification of the
specific etiologic agent and antimicrobial susceptibility
testing should be practiced during the management of
ocular infections to reduce the further emergence of
multidrug-resistant bacteria”.
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